Reuters -- A U.S. panel of medical experts backed Neuromed Pharmaceuticals Inc and Covidien's plan to limit potential abuse with their powerful, once-a-day painkiller Exalgo, saying the drug was very effective but could easily be misused.
Reuters -- A U.S. panel of medical experts backed Neuromed Pharmaceuticals Inc and Covidien's plan to limit potential abuse with their powerful, once-a-day painkiller Exalgo, saying the drug was very effective but could easily be misused.
